TBRG - TruBridge, Inc. Stock Analysis | Stock Taper
Logo
TruBridge, Inc.

TBRG

TruBridge, Inc. NASDAQ
$19.29 -2.43% (-0.48)

Market Cap $289.52 M
52w High $32.00
52w Low $17.86
Dividend Yield 1.39%
Frequency Quarterly
P/E 80.38
Volume 67.38K
Outstanding Shares 15.01M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $86.11M $39.99M $5.6M 6.51% $0.37 $14.54M
Q2-2025 $85.73M $40.83M $2.58M 3.01% $0.17 $10.37M
Q1-2025 $87.21M $39.53M $459K 0.53% $0.03 $14.72M
Q4-2024 $90.84M $40.61M $-3.06M -3.37% $-0.39 $14.1M
Q3-2024 $83.83M $39.52M $-9.81M -11.7% $0.45 $8.03M

What's going well?

Net income and earnings per share more than doubled, showing the company can turn steady sales into stronger profits. Operating expenses are under better control, and efficiency is improving.

What's concerning?

Gross margins are slipping, and interest expense is now a major drag on profits. The big jump in net income was helped by a tax benefit, which may not repeat.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $19.92K $399.41M $219.05M $180.36M
Q2-2025 $12.28M $390.15M $216.98M $173.17M
Q1-2025 $10.12M $388.84M $220.33M $168.51M
Q4-2024 $12.32M $394.43M $225.74M $168.69M
Q3-2024 $8.59M $401.53M $228.89M $172.65M

What's financially strong about this company?

The company has positive equity, improved book value, and is managing inventory well. Most debt is long-term, so there are no immediate repayment pressures.

What are the financial risks or weaknesses?

Cash reserves have collapsed, leaving the company exposed to any revenue shortfall. High debt and negative retained earnings show a risky financial position, and a big drop in intangible assets could mean recent losses or write-downs.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $5.6M $13.59M $-3.99M $-1.96M $7.64M $13.65M
Q2-2025 $2.58M $8.76M $-4.73M $-1.88M $2.15M $8.21M
Q1-2025 $459K $5.76M $-2.23M $-5.73M $-2.2M $1.43M
Q4-2024 $-3.06M $10.3M $-1.68M $-4.88M $3.74M $6.14M
Q3-2024 $-11.13M $10.11M $-5.31M $-3.92M $877K $4.8M

What's strong about this company's cash flow?

Cash from operations is growing fast, now at $13.6 million. Free cash flow is strong and rising, and the company is paying down debt while building up cash. No reliance on outside funding.

What are the cash flow concerns?

Working capital used up some cash this quarter, and shareholder returns are minimal. Stock-based compensation, while down, still dilutes shareholders a bit.

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at TruBridge, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

TruBridge combines steady revenue growth, strong and stable gross margins, and a focused niche in rural and community healthcare with a meaningful innovation agenda built around AI and analytics. Its integrated EHR and revenue cycle offerings, risk‑sharing nTrust model, and HFMA‑validated services give it credibility and stickiness with financially constrained hospitals. The business has shown it can generate solid operating cash flow in most years, and recent actions to reduce debt and improve cash generation suggest management is attentive to balance-sheet health.

! Risks

The main concerns are deteriorated profitability, increased leverage, and volatile free cash flow. Operating and interest expenses have outpaced revenue growth, leading to losses and negative retained earnings, and leaving less room for error. Higher debt levels amplify the impact of earnings swings, while liquidity metrics, although still acceptable, are trending downward. Competitive and structural risks in the rural healthcare market, plus the need to execute complex initiatives like offshore expansion and deep AI integration, add further uncertainty.

Outlook

The outlook appears mixed but improving. On one hand, the company’s niche focus, product portfolio, and AI‑driven innovation strategy position it to benefit as healthcare providers seek efficiency and automation. On the other hand, it must convert those advantages into durable profitability, stabilize cash flows, and continue to de‑risk the balance sheet. Recent improvements in EBITDA, operating income, free cash flow, and debt reduction point toward a potential turnaround, but the track record of volatility means that a sustained recovery is not yet assured and will require multiple periods of consistent execution to validate.